A Sinus implant is a medical device that is inserted into the sinus cavity. Implants can be in conjunction with sinus surgery to treat chronic sinusitis and also in sinus augmentation to increase bone structure for placement of dental implants.
Video Sinus implant
Types
Maxillary implant
A maxillary implant is an implant that is placed between jaw and the maxillary sinuses. It is inserted during a sinus lift or augmentation and used to increase the amount of bone to support dental implants. Implants are either inserted after drilling or by using a non-drilling method known as the osteotome technique. Issues such as bulging within the sinuses can occur with maxillary implants.
Maxillary implants can also be made using Choukroun's technique with subsinus filling material. The material is used to stimulate natural bone regeneration. A clinical study of this technique detailed all patients within the study had continuous stable implants six months after placement. It also showed vertical bone gain in all subjects.
Rhinoplasty
Numerous different types of material have been used as sinus implants during rhinoplasty procedures. Plaster of Paris is often used during rhinoplasty and implanted into the frontal sinus. Implants used in rhinoplasty have also been reported to cause enophthalmos.
Sinus stent
Propel mometasone furoate implant is a sinus implant used to treat inflammation associated with sinusitis. It is used as a stent and inserted into the sinus cavity during sinus surgery after an ethmoidectomy procedure, which removes bony partitions within the ethmoid sinus. It delivers steroids over a 30-day period to treat chronic sinusitis. The implant dissolves over four to six weeks and does not require removal from the sinus cavity, as well as reduces the need for additional surgical procedures and steroid pills, which can have detrimental side effects. The device was approved by the United States Food and Drug Administration on August 11, 2011.
A randomized, double-blind pilot study of sinus stents using 43 patients during an eight-week trial period showed no adverse effects. The intra-patient control design compared a drug-eluting implant to a non-steroid eluting implant. It also showed adhesion rates of 5.3% for those using Propel in comparison to 21.1% for those who received a non-steroid eluting implant. The trial showed less than 10% of stent material present after 30 days with the remaining completely absorbed by the end of the eight-week trial.
Maps Sinus implant
See also
- Bioresorbable stents
- Middle nasal concha
References
Source of article : Wikipedia
0 Comments